Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 372

1.

Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ.

Chan KC, Knox WF, Sinha G, Gandhi A, Barr L, Baildam AD, Bundred NJ.

Cancer. 2001 Jan 1;91(1):9-16.

PMID:
11148554
[PubMed - indexed for MEDLINE]
2.

Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.

Sahoo S, Recant WM, Jaskowiak N, Tong L, Heimann R.

Breast J. 2005 Jul-Aug;11(4):242-7.

PMID:
15982389
[PubMed - indexed for MEDLINE]
3.

Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy.

Rodrigues N, Carter D, Dillon D, Parisot N, Choi DH, Haffty BG.

Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1331-5.

PMID:
12459354
[PubMed - indexed for MEDLINE]
4.

Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.

Monteau A, Sigal-Zafrani B, Kirova YM, Fourchotte V, Bollet MA, Vincent-Salomon A, Asselain B, Salmon RJ, Fourquet A.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1021-8. doi: 10.1016/j.ijrobp.2008.12.014. Epub 2009 Apr 20.

PMID:
19386441
[PubMed - indexed for MEDLINE]
5.

Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.

Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keisch M, Dipetrillo T, Khan D, Hudes R.

Am J Surg. 2006 Oct;192(4):427-33.

PMID:
16978943
[PubMed - indexed for MEDLINE]
6.

Treatment for ductal carcinoma in situ in an Asian population: outcome and prognostic factors.

Chuwa EW, Tan VH, Tan PH, Yong WS, Ho GH, Wong CY.

ANZ J Surg. 2008 Jan-Feb;78(1-2):42-8. doi: 10.1111/j.1445-2197.2007.04354.x.

PMID:
18199204
[PubMed - indexed for MEDLINE]
7.

Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast.

Macdonald HR, Silverstein MJ, Lee LA, Ye W, Sanghavi P, Holmes DR, Silberman H, Lagios M.

Am J Surg. 2006 Oct;192(4):420-2.

PMID:
16978941
[PubMed - indexed for MEDLINE]
8.

Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies.

Lagios MD, Silverstein MJ.

Surg Oncol Clin N Am. 1997 Apr;6(2):385-92.

PMID:
9115503
[PubMed - indexed for MEDLINE]
9.

Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.

Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1514-21. Epub 2005 Jul 11.

PMID:
16005576
[PubMed - indexed for MEDLINE]
10.

The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast.

Neuschatz AC, DiPetrillo T, Steinhoff M, Safaii H, Yunes M, Landa M, Chung M, Cady B, Wazer DE.

Cancer. 2002 Apr 1;94(7):1917-24.

PMID:
11932892
[PubMed - indexed for MEDLINE]
Free Article
11.

Long-term outcome for mammographically detected ductal carcinoma in situ managed with breast conservation treatment: prognostic significance of reexcision.

Vapiwala N, Harris E, Hwang WT, Solin LJ.

Cancer J. 2006 Jan-Feb;12(1):25-32.

PMID:
16613659
[PubMed - indexed for MEDLINE]
12.

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.

EORTC Breast Cancer Cooperative Group; EORTC Radiotherapy Group, Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, Julien JP, Gennaro M, Rouanet P, Avril A, Fentiman IS, Bartelink H, Rutgers EJ.

J Clin Oncol. 2006 Jul 20;24(21):3381-7. Epub 2006 Jun 26.

PMID:
16801628
[PubMed - indexed for MEDLINE]
Free Article
13.

Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age.

Goldstein NS, Vicini FA, Kestin LL, Thomas M.

Cancer. 2000 Jun 1;88(11):2553-60.

PMID:
10861433
[PubMed - indexed for MEDLINE]
14.

Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.

Cabioglu N, Krishnamurthy S, Kuerer HM, Hunt KK, Singletary SE, Meric-Bernstam F, Ross MI, Feig BW, Ames FC, Babiera GV.

Cancer. 2004 Aug 1;101(3):508-17.

PMID:
15274063
[PubMed - indexed for MEDLINE]
Free Article
15.

Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.

Boland GP, Chan KC, Knox WF, Roberts SA, Bundred NJ.

Br J Surg. 2003 Apr;90(4):426-32.

PMID:
12673743
[PubMed - indexed for MEDLINE]
16.

Factors affecting successful breast conservation for ductal carcinoma in situ.

Dillon MF, Mc Dermott EW, O'Doherty A, Quinn CM, Hill AD, O'Higgins N.

Ann Surg Oncol. 2007 May;14(5):1618-28. Epub 2007 Feb 14.

PMID:
17443388
[PubMed - indexed for MEDLINE]
17.

Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.

Olson TP, Harter J, Muñoz A, Mahvi DM, Breslin T.

Ann Surg Oncol. 2007 Oct;14(10):2953-60. Epub 2007 Aug 3.

PMID:
17674109
[PubMed - indexed for MEDLINE]
18.

Predictors of surgical margin status in breast-conserving surgery within a breast screening program.

Kurniawan ED, Wong MH, Windle I, Rose A, Mou A, Buchanan M, Collins JP, Miller JA, Gruen RL, Mann GB.

Ann Surg Oncol. 2008 Sep;15(9):2542-9. doi: 10.1245/s10434-008-0054-4. Epub 2008 Jul 10.

PMID:
18618180
[PubMed - indexed for MEDLINE]
19.

Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.

Jenkinson AD, Al-Mufti RA, Mohsen Y, Berry MJ, Wells C, Carpenter R.

Eur J Surg Oncol. 2001 Feb;27(1):21-5.

PMID:
11237487
[PubMed - indexed for MEDLINE]
20.

Predictors of local recurrence following excision alone for ductal carcinoma in situ.

Hetelekidis S, Collins L, Silver B, Manola J, Gelman R, Cooper A, Lester S, Lyons JA, Harris JR, Schnitt SJ.

Cancer. 1999 Jan 15;85(2):427-31.

PMID:
10023711
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk